| In FTC Case Against Shkreli
He Must Pay $65M And Is Banned from Pharma
Industry in SDNY
By Matthew
Russell Lee, Patreon Order
BBC
- Guardian
UK - Honduras
- The
Source
SDNY COURTHOUSE,
Dec 13 – In the case
against Martin Shkreli for
blocking generic competition
to Daraprim, brought by the
Federal Trade Commission and a
group of state attorneys
general, there was a telephone
conference publicized for May
27, 2020 at 2:30 by before
U.S. District Court for the
Southern District of New York
Magistrate Judge Robert W.
Lehrburger.
Inner City Press
called in with the telephone
number and access code which
were published on PACER.
Judge Lehrburger,
after asking for the name of
each lawyer for defendants and
plaintiffs on the call, even
if they would not speak, said
there were four more people on
the line.
He
asked each to identify
themselves. Inner City Press
immediately said, "Inner City
Press."
Judge Lehrburger said it was a
settlement call, even though
PACER listed is a call in
advance of a settlement
conference in June. Inner City
Press pointed out that it was
listed as a Notable
Proceeding. Judge Lehrburger
said, Thank you for bowing
out.
So Inner
City Press disconnected from
the call, and sent out this
tweet:
In a case by
Federal Trade Commission and
AGs of NY & other states
against Martin Shkreli &
Vyera Pharma, from a
pre-settlement conference
telephone call listed in PACER
Inner City Press was just told
to "bow out" - hang up - by
SDNY Judge Lehrberger.
This case, from
which the Press was just told
to "bow out," is about Shkreli
and Vyera and their "scheme to
block lower-cost generic
competition to Daraprim, which
treats potentially fatal
parasitic infection
toxoplasmosis."
Time moved
on. On November 16, 2021
District Judge Denise L. Cote
held a telephone proceeding in
the case and Inner City Press
covered it without incident.
In fact, it live tweeted:
Now FTC v. Martin
#Shkreli, with many states on
the line.
Judge Cote: He
access must be restricted in
an appropriate way, but I
don't think we need to address
it at this point.
Shkreli's lawyer:
We joined Mr. Mulleady's
motion.
Judge Cote: Mr.
Shkreli has chosen to absent
himself from trial, so he
won't have more rights.
Judge Cote: That
is it for today. Have a good
holiday and stay safe.
But then on
December 13, when Inner City
Press went to the courtroom,
it was very quickly sealed. An
hour later when Inner City
Press went back, it was still
sealed. This is a public
interest case by the FTC?
On January 14,
2022 Judge Cote issued a 135
page order, which we've put on
DocumentCloud here,
finding Shkreli liable,
banning him for life from the
pharmaceutical industry, and
ordering him to pay $64.6
million to the complaining
states. We'll have more on
this.
The case is
Federal Trade Commission et al
v. Vyera Pharmaceuticals, LLC
et al., 20-cv-706 (Cote /
Lehrburger).
***
Your
support means a lot. As little as $5 a month
helps keep us going and grants you access to
exclusive bonus material on our Patreon
page. Click
here to become a patron.
Feedback:
Editorial [at] innercitypress.com
SDNY Press Room 480, front cubicle
500 Pearl Street, NY NY 10007 USA
Mail: Box 20047, Dag
Hammarskjold Station NY NY 10017
Reporter's mobile (and weekends):
718-716-3540
Other, earlier Inner City Press are
listed here,
and some are available in the ProQuest
service, and now on Lexis-Nexis.
Copyright 2006-2019 Inner City
Press, Inc. To request reprint or other
permission, e-contact Editorial [at]
innercitypress.com for
|
,
